Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephen Hoge currently holds 1,454,905 shares of Moderna, Inc. (MRNA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen Hoge has been a net seller of MRNA stock. They have purchased $0 and sold $295.8M worth of shares.
Stephen Hoge's most recent insider trade was on Dec 1, 2025, when they sold 316 shares at $25.98 per share.
Stephen Hoge serves as Executive at Moderna, Inc. (MRNA). They have executed 718 insider transactions totaling $295.8M over their tenure at the company.
Stephen Hoge holds the position of Executive at Moderna, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Stephen Hoge has shown a selling trading pattern, with $0 in total purchases and $295.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stephen Hoge was on Jun 17, 2024, when they sold $2.1M worth of MRNA shares. This transaction involved 15,000 shares at $138.16 per share.
Stephen Hoge currently owns 1,454,905 shares of Moderna, Inc. (MRNA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephen Hoge's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephen Hoge has 718 Form 4 filings on record as an insider at Moderna, Inc..
Set alerts for Stephen Hoge and 40,000+ other insiders.